Search

25 February 2017 The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes"

27 Feb 2017 - 16:30

SATVI authors Professor Mark Hatherill, Associate Professor Tom Scriba and Dr Munyaradzi Musvosvi have co-authored a paper titled "The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes" appearing in the Tuberculosis Journal.

To view abstract Click Here.